ORGANOGENESIS HOLDINGS INC. Finance Lease, Principal Payments
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Finance Lease, Principal Payments of $10.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. finance lease, principal payments for the quarter ending 2026-06-30 was $348.00K, a 20.83% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. finance lease, principal payments for the quarter ending 2026-03-31 was $9.84M, a 3352.63% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. finance lease, principal payments for the quarter ending 2025-12-31 was $302.00K, a 9.03% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. finance lease, principal payments for the quarter ending 2025-09-30 was $296.00K, a 7.25% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. finance lease, principal payments for fiscal 2025 was $1.17M, a 8.33% increase from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. finance lease, principal payments for fiscal 2024 was $1.08M, a 122.89% increase from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. finance lease, principal payments for fiscal 2023 was $485.00K, a 142.50% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. finance lease, principal payments for fiscal 2022 was $200.00K, a 92.40% decline from fiscal 2021.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.19M 10-Q · filed 2026-08-06 | $10.49M derived: sum of 3 quarters · filed 2026-08-06 | $10.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $9.84M 10-Q · filed 2026-05-07 | $10.14M derived: sum of 2 quarters · filed 2026-05-07 | $10.44M derived: sum of 3 quarters · filed 2026-05-07 | $10.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $598.00K derived: sum of 2 quarters · filed 2026-02-26 | $886.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.17M 10-K · filed 2026-02-26 |
| 2025-09-30 | $296.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $584.00K derived: sum of 2 quarters · filed 2026-08-06 | $869.00K 10-Q · filed 2025-11-06 | $1.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $288.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $573.00K 10-Q · filed 2026-08-06 | $850.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $285.00K 10-Q · filed 2026-05-07 | $562.00K derived: sum of 2 quarters · filed 2026-05-07 | $838.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.10M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $553.00K derived: sum of 2 quarters · filed 2026-02-26 | $819.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.08M 10-K · filed 2026-02-26 |
| 2024-09-30 | $276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $542.00K derived: sum of 2 quarters · filed 2025-11-06 | $804.00K 10-Q · filed 2025-11-06 | $1.18M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $528.00K 10-Q · filed 2025-08-07 | $899.00K derived: sum of 3 quarters · filed 2026-02-26 | $930.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $262.00K 10-Q · filed 2025-05-08 | $633.00K derived: sum of 2 quarters · filed 2026-02-26 | $664.00K derived: sum of 3 quarters · filed 2026-02-26 | $747.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $402.00K derived: sum of 2 quarters · filed 2026-02-26 | $485.00K derived: sum of 3 quarters · filed 2026-02-26 | $485.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $114.00K derived: sum of 2 quarters · filed 2024-11-12 | $114.00K 10-Q · filed 2024-11-12 | $114.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $83.00K 10-Q · filed 2024-08-08 | $83.00K derived: sum of 3 quarters · filed 2025-02-27 | $83.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $101.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $101.00K derived: sum of 3 quarters · filed 2025-02-27 | $200.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $101.00K derived: sum of 2 quarters · filed 2023-11-09 | $200.00K 10-Q · filed 2023-11-09 | $731.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $200.00K 10-Q · filed 2023-08-09 | $731.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.46M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $99.00K 10-Q · filed 2023-05-10 | $630.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.35M derived: sum of 3 quarters · filed 2024-02-29 | $2.05M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $531.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.26M derived: sum of 2 quarters · filed 2024-02-29 | $1.96M derived: sum of 3 quarters · filed 2024-02-29 | $2.63M 10-K · filed 2024-02-29 |
| 2021-09-30 | $725.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.42M derived: sum of 2 quarters · filed 2022-11-09 | $2.10M 10-Q · filed 2022-11-09 | $2.75M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $699.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.37M 10-Q · filed 2022-08-09 | $2.02M derived: sum of 3 quarters · filed 2023-03-01 | $2.65M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $675.00K 10-Q · filed 2022-05-10 | $1.33M derived: sum of 2 quarters · filed 2023-03-01 | $1.95M derived: sum of 3 quarters · filed 2023-03-01 | $2.56M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $651.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.28M derived: sum of 2 quarters · filed 2023-03-01 | $1.88M derived: sum of 3 quarters · filed 2023-03-01 | $2.43M 10-K · filed 2023-03-01 |
| 2020-09-30 | $627.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.23M derived: sum of 2 quarters · filed 2021-11-09 | $1.78M 10-Q · filed 2021-11-09 | $2.18M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.15M 10-Q · filed 2021-08-09 | $1.55M derived: sum of 3 quarters · filed 2022-03-01 | $1.86M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $544.00K 10-Q · filed 2021-05-11 | $947.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.25M derived: sum of 3 quarters · filed 2022-03-01 | $1.60M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $709.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.06M derived: sum of 3 quarters · filed 2022-03-01 | $1.27M 10-K · filed 2022-03-01 |
| 2019-09-30 | $306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $654.00K derived: sum of 2 quarters · filed 2020-11-09 | $863.00K 10-Q · filed 2020-11-09 | $950.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $557.00K 10-Q · filed 2020-08-10 | $644.00K derived: sum of 3 quarters · filed 2021-03-16 | $644.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $209.00K 10-Q · filed 2020-05-11 | $296.00K derived: sum of 2 quarters · filed 2021-03-16 | $296.00K derived: sum of 3 quarters · filed 2021-03-16 | $295.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $87.00K derived: sum of 2 quarters · filed 2021-03-16 | $86.00K derived: sum of 3 quarters · filed 2021-03-16 | $104.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.00K derived: sum of 2 quarters · filed 2019-11-12 | $17.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $17.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $18.00K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $81.00K 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |